✦ LIBER ✦

527 CDKN2a Promoter Hypermethylation is Associated With Environmental Risk Factors in Patients With Laryngeal Carcinoma

✍ Scribed by S. Pierini; S. Jordanov; A. Mitkova; I. Chalakov; R. Kaneva; V. Mitev; M. Melnicharov; T. Goranova

Book ID: 117663023
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 52 KB
Volume: 48
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(12)71187-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

CDKN2A promoter hypermethylation in astr

CDKN2A promoter hypermethylation in astrocytomas is associated with age and sex

✍ Alves, Markênia Kélia Santos; Faria, Mário Henrique Girão; Neves Filho, Eduardo 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 723 KB

Promoter hypermethylation of CDKN2A , MG

Promoter hypermethylation of CDKN2A , MGMT , MLH1 , and DAPK genes in laryngeal squamous cell carcinoma and their associations with clinical profiles of the patients

✍ Pierini, Stefano; Jordanov, Stanislav H.; Mitkova, Atanaska V.; Chalakov, Ivan J 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 549 KB

Promoter hypermethylation of DAP-kinase

Promoter hypermethylation of DAP-kinase is associated with poor survival in primary biliary tract carcinoma patients

✍ Tomohiro Tozawa; Gen Tamura; Teiichiro Honda; Shin-ichi Nawata; Wataru Kimura; N 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 333 KB

Regulatory BCL2 promoter polymorphism (−

Regulatory BCL2 promoter polymorphism (−938C>A) is associated with adverse outcome in patients with prostate carcinoma

✍ Hagen S. Bachmann; Lukas C. Heukamp; Klaus J. Schmitz; Caroline F. Hilburn; Phil 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 French ⚖ 539 KB

## Abstract Molecular markers predictive of prostate cancer prognosis are urgently needed. Overexpression of the antiapoptotic protein, Bcl‐2, has repeatedly been shown to be associated with adverse outcome in this malignancy. We hypothesized that a regulatory __BCL2__ −938C>A promoter polymorphism

MSH2 promoter hypermethylation in circul

MSH2 promoter hypermethylation in circulating tumor DNA is a valuable predictor of disease-free survival for patients with esophageal squamous cell carcinoma

✍ Z.Q. Ling; Q. Zhao; S.L. Zhou; W.M. Mao 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 434 KB

Associations of risk factors obesity and

Associations of risk factors obesity and occupational airborne exposures with CDKN2A/p16 aberrant DNA methylation in esophageal cancer patients

✍ S. Mohammad Ganji; E. Miotto; E. Callegari; K. Sayehmiri; F. Fereidooni; M. Yazd 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB